+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Biomaterials Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 5797876
The global biomaterials market was valued at USD 146.58 Billion in 2024, driven by the increasing prevalence of musculoskeletal disorders, osteoarthritis and other chronic skeletal conditions among others across the globe. The market is anticipated to grow at a CAGR of 14.20% during the forecast period of 2025-2034 to achieve a value of USD 553.01 Billion by 2034.

The global biomaterials market is expanding due to increasing demand for advanced biomaterials in orthopedic implants and implant-based biomaterials. Rising cases of musculoskeletal conditions, particularly chronic skeletal conditions, drive market demand, with osteoarthritis treatments and joint replacement surgery becoming more prevalent. Innovations in joint augmentations and healthcare biomaterials enhance patient outcomes. The biomaterials market growth is supported by improved research in degenerative diseases, ensuring enhanced safety and effectiveness. With a strong focus on innovation, the market is projected to witness significant CAGR growth in biomaterials, positioning it as a critical sector in modern healthcare.

Metallic biomaterials play a vital role in durable medical implants due to their biocompatibility, corrosion resistance, and integration with biological systems. Medical-grade metals are widely used for implant materials, supporting functional restoration and extending lifespan. Technological advancements in biomaterials continue to improve body-compatible metals, reinforcing their importance in biomedical engineering materials for safer and more effective medical applications.

Biomaterials Market Trends

The demand for implantable biomaterials is rising due to advancements in biocompatible materials that enhance tissue integration and improve medical implants. Orthopedic biomaterials are essential for chronic conditions treatment, particularly in age-related injuries requiring advanced biomaterials for healing. The development of durable medical implants is critical for ensuring long-term functionality, particularly in biomaterials for elderly population. Biomedical engineering solutions aim to enhance implant complications reduction, minimising risks and improving healing and tissue regeneration. Bioactive materials are driving innovation by promoting faster healing, positioning innovative healthcare materials as a key trend in the industry.

Biomaterials for tissue engineering are transforming medical applications, supported by nanotechnology in medicine for enhanced efficiency. Tissue replacement materials aid in bone and organ repair, expanding the scope of advanced biomaterials applications. Addressing immune rejection in tissue transplant, researchers are developing allograft and autograft alternatives to mitigate dependency on human donors. The donor shortage in tissue replacement is accelerating the adoption of nanotechnology-enabled biomaterials, significantly improving the efficacy of regenerative medicine biomaterials in restoring damaged tissues.

Polymeric biomaterials are gaining traction due to their adaptability in extracellular matrix mimicking materials and 3D printable biomaterials. Osteoconductive biomaterials support implant material innovations, enhancing cell growth scaffolds for improved healing. Medical-grade polymers, including PEEK filament for implants, are widely used, with manufacturers like Evonik biomaterials leading the sector. Improved bone-implant integration and advanced polymeric implants contribute to long-term success. Ongoing biomedical polymer research is refining implantable biomaterials, while tissue engineering scaffolds offer promising solutions for complex medical challenges.

Market Concentration and Characteristics

The biomaterials market is moderately concentrated, with leading companies driving innovation through research and development. Large firms dominate due to extensive patent portfolios, strong distribution networks, and regulatory expertise. However, emerging players contribute to market expansion by introducing advanced biomaterials with specialised applications. Strategic partnerships, mergers, and acquisitions are common as companies aim to enhance technological capabilities and global reach. The increasing demand for biocompatible materials in medical implants fosters competition, encouraging manufacturers to develop next-generation solutions for orthopedic, dental, and cardiovascular applications. Regulatory compliance and product approvals remain critical factors shaping market entry and expansion strategies. Growing investments in biomedical polymer research are further enhancing market competitiveness.

Market concentration is influenced by raw material availability, stringent regulatory requirements, and production costs. Leading companies benefit from economies of scale, ensuring competitive pricing and sustained growth, while smaller firms focus on niche innovations.

The market is characterised by continuous technological advancements, with innovations in implantable biomaterials, polymeric biomaterials, and tissue engineering solutions. Increasing demand for nanotechnology-enabled biomaterials and 3D printable biomaterials is reshaping product development, improving patient outcomes.

With rising applications in regenerative medicine, drug delivery systems, and personalized healthcare, the biomaterials market is expanding. Ageing populations, increased healthcare investments, and ongoing biomedical polymer research drive long-term industry growth and diversification.

Product Type Insights

Natural biomaterials are gaining prominence due to their biocompatibility and ability to support tissue regeneration. Derived from sources like cellulose, gelatin, and hyaluronic acid, they are widely used in wound healing, tissue engineering, and drug delivery systems. Their biodegradable nature reduces long-term complications, making them ideal for regenerative medicine applications. Metallic biomaterials, including stainless steel, gold and cobalt-chromium alloys, remain essential for orthopaedic implants, dental prosthetics, and cardiovascular stents due to their high strength, durability, and corrosion resistance. Advances in medical-grade metals enhance integration with biological systems, improving bone-implant stability and long-term functionality in medical applications.

Ceramic biomaterials, such as calcium phosphate, aluminium oxide and glass are widely used in dental implants, joint replacements, and bone grafts due to their excellent osteoconductive properties. Their ability to bond naturally with bone structures enhances bone regeneration and implant longevity. Meanwhile, polymeric biomaterials are revolutionising healthcare applications through innovations in 3D printable biomaterials, biodegradable implants, and tissue engineering scaffolds. Materials like PEEK (polyether ether ketone) and polylactic acid (PLA) offer flexibility, biocompatibility, and resistance to mechanical stress, making them suitable for customised implants. Ongoing research in biomedical polymers is expanding the scope of implantable biomaterials, improving patient-specific treatment options and driving innovation in advanced medical solutions.

Application Insights

The biomaterials market plays a crucial role in diverse medical applications. In cardiovascular care, sensors, stents, pacemakers, and vascular grafts improve patient outcomes by enhancing heart function and blood circulation. Ophthalmology benefits from synthetic corneas, intraocular lenses, and ocular tissue replacements, aiding vision restoration. Dental applications, including tissue regeneration materials, dental implants, and grafts, support oral health and bone integration. Orthopaedic biomaterials, such as orthobiologics, viscosupplementation, and spine biomaterials, enhance joint function and bone repair. Additionally, wound healing biomaterials, including fracture healing devices and internal tissue sealants, accelerate tissue recovery and minimise complications.

Emerging applications in tissue engineering and plastic surgery utilise acellular dermal matrices, soft tissue fillers, and peripheral nerve repair materials for reconstructive procedures. Neurological and central nervous system biomaterials improve outcomes through neural stem cell encapsulation, hydrogel scaffolds for CNS repair, and cortical neural prosthetics, supporting nerve regeneration. Ongoing advancements in hydrogels, bioactive materials, and 3D-printed biomaterials further expand possibilities across medical fields, driving innovation and improving patient care. The biomaterials market continues to evolve, offering solutions that enhance longevity, reduce complications, and improve the quality of life across multiple healthcare sectors.

Regional Insights

The global biomaterials market is expanding significantly due to rising healthcare investments, technological advancements, and increasing demand for implantable biomaterials in medical applications. Developed regions, such as North America and Europe, dominate due to well-established healthcare infrastructures, regulatory support, and high adoption rates of biocompatible materials. Meanwhile, the Asia-Pacific region is witnessing rapid growth, driven by increasing healthcare expenditure, ageing populations, and advancements in tissue engineering. The Middle East and Africa market is growing steadily, with government initiatives supporting medical implants, wound healing, and regenerative medicine applications. Innovation and research investments continue to shape regional market trends.

U.S. Biomaterials Market Trends

The United States biomaterials market leads globally due to extensive R&D investments, a high prevalence of chronic diseases, and an ageing population requiring advanced medical implants. The demand for orthopaedic, cardiovascular, and dental biomaterials is rising, driven by increasing joint replacement surgeries and heart-related procedures. Technological advancements in 3D printing, nanotechnology, and polymer-based biomaterials are expanding treatment options. Moreover, regulatory approvals from the FDA ensure the availability of high-quality biomaterials. The strong presence of key industry players, collaborations between biotechnology firms and medical institutions, and funding for biomedical research contribute to market growth.

Europe Biomaterials Market Trends

The European biomaterials market is witnessing substantial growth due to government support, an ageing population, and increased demand for tissue engineering solutions. The rising adoption of biodegradable implants, polymer-based biomaterials, and regenerative medicine applications is driving expansion. Additionally, regulatory frameworks such as the European Medical Device Regulation (MDR) ensure the safety and quality of biomaterial products. Sustainable biomaterials and innovations in nanotechnology are shaping future developments.

Biomaterials market in the UK is driven by advancements in biomedical engineering and rising demand for dental, cardiovascular, and orthopaedic biomaterials. The country's strong healthcare system and research institutions support innovation in 3D printable biomaterials, bioactive materials, and personalised implants. For instance, in July 2024, a UK-based company developing a versatile biomaterial suitable for 3D printed implants and surgical devices secured EUR 3.4 million (USD 4.4 million) in Series A funding. This investment will support pre-clinical testing and facilitate the company’s efforts to obtain FDA clearance for expansion into the US market.

Germany biomaterials market is a leader in the European biomaterials market, known for its advanced healthcare infrastructure, medical device manufacturing, and biotechnology sector. The country invests heavily in biomedical polymer research, nanotechnology-enabled biomaterials, and sustainable implants. The demand for orthopaedic, cardiovascular, and dental biomaterials is increasing due to a growing elderly population.

The market for biomaterials in France is expanding due to the rising adoption of regenerative medicine, personalised healthcare, and tissue engineering solutions. French companies are investing in biodegradable implants, synthetic grafts, and osteoconductive biomaterials for orthopaedic and dental applications. The government’s support for biomedical research and partnerships between universities and biotech firms are accelerating innovation. Additionally, France is at the forefront of nanotechnology applications in medicine, contributing to developments in biocompatible polymers, hydrogels, and drug delivery systems. Strong regulatory frameworks and increasing demand for advanced biomaterials in plastic surgery and cardiovascular treatments further drive market growth.

Asia-Pacific Biomaterials Market Trends

The Asia-Pacific biomaterials market is experiencing rapid expansion due to increasing healthcare investments, a rising geriatric population, and a growing focus on medical-grade polymers and implantable biomaterials. Countries like Japan, China, and India are major contributors, with advancements in nanotechnology, 3D printing, and bioactive materials improving healthcare solutions. The rising prevalence of chronic diseases, musculoskeletal conditions, and cardiovascular disorders is increasing the demand for orthopaedic, dental, and cardiovascular biomaterials across the region. Government funding and strategic collaborations with global medical companies are further driving market growth.

Japan biomaterials market is highly advanced, supported by biomedical innovation and an ageing population. For instance, in July 2024, Tokyo-based Mochida Pharmaceutical received FDA 510(k) clearance for ReFeel, a nerve regeneration sheet made from sodium alginate and polyglycolic acid. Marking its first regulatory success in biomaterials, Mochida also planned a US launch and is also developing dMD-002 in Japan for cavernous nerve injury, reinforcing the nation’s role in regenerative medicine.

The biomaterials market in China is also expanding rapidly due to increasing healthcare spending, a growing ageing population, and rising demand for orthopaedic, cardiovascular, and wound healing biomaterials. China’s focus on domestic biomaterials production, implantable biomaterials, and tissue engineering is driving innovation. Investments in medical-grade polymers, ceramic biomaterials, and bioactive materials are increasing. Additionally, partnerships between research institutions and biotechnology companies are accelerating developments in biocompatible materials and regenerative medicine applications. Government initiatives promoting biomedical engineering and nanotechnology research further support market expansion.

Middle East and Africa Biomaterials Market Trends

The biomaterials market in the Middle East and Africa is growing due to rising healthcare investments, government initiatives, and an increasing focus on regenerative medicine and implantable biomaterials. The UAE, Saudi Arabia, and South Africa are key markets, with expanding healthcare infrastructures and increasing demand for orthopaedic, dental, and cardiovascular biomaterials. The adoption of biodegradable implants, nanotechnology-enabled biomaterials, and polymer-based scaffolds is rising. Research collaborations and partnerships with international medical firms are boosting biomedical polymer research and medical-grade metals applications. Growth in plastic surgery, wound healing, and tissue engineering is also contributing to market expansion.

The South Africa biomaterials market is growing due to increased demand for orthopaedic, dental, and cardiovascular biomaterials. The country’s healthcare sector is adopting biodegradable implants, polymer-based biomaterials, and bioactive scaffolds to improve patient outcomes. Government investments in biomedical research, regenerative medicine, and medical device manufacturing are supporting industry growth. Additionally, collaborations between universities, biotechnology firms, and global healthcare companies are driving innovation. The rising prevalence of chronic conditions, musculoskeletal disorders, and joint diseases is increasing the demand for advanced biomaterials, making South Africa a key market in the Middle East and Africa region.

Key Biomaterials Company Insights

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Koninklijke DSM N.V

Koninklijke DSM N.V. is a global leader in biomaterials and biomedical solutions, specialising in biocompatible polymers, regenerative medicine, and medical-grade materials. The company focuses on tissue engineering, drug delivery systems, and orthopaedic applications, offering sustainable, bio-based solutions.

Corbion N.V

Corbion N.V. is renowned for its biodegradable polymers and lactic acid-based biomaterials. The company provides advanced biomaterials for medical implants, tissue regeneration, and controlled drug delivery. Its polylactic acid (PLA)-based materials are widely used in orthopaedic, dental, and wound healing applications.

Zimmer Biomet

Zimmer Biomet is a leading manufacturer of orthopaedic biomaterials, implantable medical devices, and bone graft substitutes. The company specialises in joint replacement, spine biomaterials, and regenerative solutions.

Noble Biomaterials Inc

Noble Biomaterials pioneers in antimicrobial and conductive biomaterials for wound care, infection control, and medical textiles. Its proprietary silver-based technologies, such as Ionic+®, enhance biocompatibility and infection resistance.

Other key players in the market include BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Evonik Industries AG, Victrex plc, CeramTec GmbH and Coorstek Inc

Recent Developments

  • In March 2025, Rayonier Advanced Materials (NYSE: RYAM) outlined its strategic shift from commodity production to high-margin biomaterials at Gabelli Funds’ 16th Annual Specialty Chemicals Symposium. This move enhances innovation in cellulose-based biomaterials, supporting sustainability and efficiency. Despite challenges like tariff risks and debt reduction, the transition strengthens the biomaterials sector by increasing investment in advanced cellulose products, improving market growth, and reducing reliance on traditional chemicals.
  • In October 2024, Celularity Inc. acquired Rebound, a full-thickness placental-derived allograft matrix from Sequence LifeScience. This addition enhances Celularity’s regenerative biomaterials portfolio for wound care and soft tissue repair. The acquisition strengthens the company’s ability to serve a broader patient population, reinforcing its leadership in placental-based biomaterials. It also advances natural, biologically derived solutions that accelerate healing, further propelling biomaterials adoption in regenerative medicine.
  • In July 2023, Biocoat Inc. acquired Chempilots, a European specialty polymer provider for medical devices. This acquisition broadens Biocoat’s biomaterial platform, enabling the development of innovative hydrophilic coatings and advanced polymers. By integrating Chempilots’ expertise, Biocoat strengthens its presence in the medical biomaterials market, facilitating the creation of customised, high-performance coatings that enhance medical device functionality and expand market reach globally.
  • In May 2021, Origin.Bio raised USD 15 million in funding led by EQT Ventures to develop synthetic biomaterials that replace petrochemical-based ingredients. The investment accelerates research into bioengineered materials, leveraging AI and automation for sustainable biomaterial production. By reducing reliance on fossil fuels and integrating biotechnology into manufacturing, this funding strengthens biomaterials innovation, paving the way for eco-friendly alternatives in industrial applications.

Global Biomaterials Market Report Segmentation

Biomaterials Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

  • Metallic
  • Stainless Steel
  • Gold
  • Cobalt-Chrome
  • Others
  • Natural
  • Hyaluronic Acid
  • Cellulose
  • Gelatin
  • Others
  • Ceramics
  • Calcium Phosphate
  • Aluminum Oxide
  • Glass
  • Others
  • Polymers
  • Polyethylene
  • Polyester
  • Nylon
  • Others

Market Breakup by Application

  • Orthopedic
  • Orthobiologics
  • Viscosupplementation
  • Spine Biomaterials
  • Others
  • Cardiovascular
  • Sensors
  • Stents
  • Pacemakers
  • Vascular Grafts
  • Others
  • Ophthalmology
  • Synthetic Corneas
  • Intraocular Lens
  • Contact Lens
  • Ocular Tissue Replacement
  • Others
  • Dental
  • Tissue Regeneration Materials
  • Dental Implants
  • Grafts and Substitutes
  • Others
  • Plastic Surgery
  • Soft Tissue Fillers
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
  • Wound Healing
  • Fracture Healing Devices
  • Adhesion Barrier
  • Internal Tissue Sealant
  • Others
  • Tissue Engineering
  • Neurological/Central Nervous System
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold for CNS Repair
  • Cortical Neural Prosthetics
  • Others
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biomaterials Market Overview
3.1 Global Biomaterials Market Historical Value (2018-2024)
3.2 Global Biomaterials Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Biomaterials Market Landscape*
5.1 Global Biomaterials Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Biomaterials Market: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 Global Biomaterials Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Biomaterials Market Segmentation (218-2034)
7.1 Global Biomaterials Market (2018-2034) by Product Type
7.1.1 Market Overview
7.1.2 Metallic
7.1.2.1 Stainless Steel
7.1.2.2 Gold
7.1.2.3 Cobalt-Chrome
7.1.2.4 Others
7.1.3 Natural
7.1.3.1 Hyaluronic Acid
7.1.3.2 Cellulose
7.1.3.3 Gelatin
7.1.3.4 Others
7.1.4 Ceramics
7.1.4.1 Calcium Phosphate
7.1.4.2 Aluminum Oxide
7.1.4.3 Glass
7.1.4.4 Others
7.1.5 Polymers
7.1.5.1 Polyethylene
7.1.5.2 Polyester
7.1.5.3 Nylon
7.1.5.4 Others
7.2 Global Biomaterials Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Orthopedic
7.2.2.1 Orthobiologics
7.2.2.2 Viscosupplementation
7.2.2.3 Spine Biomaterials
7.2.2.4 Others
7.2.3 Cardiovascular
7.2.3.1 Sensors
7.2.3.2 Stents
7.2.3.3 Pacemakers
7.2.3.4 Vascular Grafts
7.2.3.5 Others
7.2.4 Ophthalmology
7.2.4.1 Synthetic Corneas
7.2.4.2 Intraocular Lens
7.2.4.3 Contact Lens
7.2.4.4 Ocular Tissue Replacement
7.2.4.5 Others
7.2.5 Dental
7.2.5.1 Tissue Regeneration Materials
7.2.5.2 Dental Implants
7.2.5.3 Grafts and Substitutes
7.2.5.4 Others
7.2.6 Plastic Surgery
7.2.6.1 Soft Tissue Fillers
7.2.6.2 Peripheral Nerve Repair
7.2.6.3 Acellular Dermal Matrices
7.2.6.4 Others
7.2.7 Wound Healing
7.2.7.1 Fracture Healing Devices
7.2.7.2 Adhesion Barrier
7.2.7.3 Internal Tissue Sealant
7.2.7.4 Others
7.2.8 Tissue Engineering
7.2.9 Neurological/Central Nervous System
7.2.9.1 Neural Stem Cell Encapsulation
7.2.9.2 Shunting Systems
7.2.9.3 Hydrogel Scaffold for CNS Repair
7.2.9.4 Cortical Neural Prosthetics
7.2.9.5 Others
7.2.10 Others
7.3 Global Biomaterials Market (2018-2034) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Biomaterials Market (218-2034)
8.1 North America Biomaterials Market (2018-2034) by Product Type
8.1.1 Market Overview
8.1.2 Metallic
8.1.2.1 Stainless Steel
8.1.2.2 Gold
8.1.2.3 Cobalt-Chrome
8.1.2.4 Others
8.1.3 Natural
8.1.3.1 Hyaluronic Acid
8.1.3.2 Cellulose
8.1.3.3 Gelatin
8.1.3.4 Others
8.1.4 Ceramics
8.1.4.1 Calcium Phosphate
8.1.4.2 Aluminum Oxide
8.1.4.3 Glass
8.1.4.4 Others
8.1.5 Polymers
8.1.5.1 Polyethylene
8.1.5.2 Polyester
8.1.5.3 Nylon
8.1.5.4 Others
8.2 North America Biomaterials Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Orthopedic
8.2.2.1 Orthobiologics
8.2.2.2 Viscosupplementation
8.2.2.3 Spine Biomaterials
8.2.2.4 Others
8.2.3 Cardiovascular
8.2.3.1 Sensors
8.2.3.2 Stents
8.2.3.3 Pacemakers
8.2.3.4 Vascular Grafts
8.2.3.5 Others
8.2.4 Ophthalmology
8.2.4.1 Synthetic Corneas
8.2.4.2 Intraocular Lens
8.2.4.3 Contact Lens
8.2.4.4 Ocular Tissue Replacement
8.2.4.5 Others
8.2.5 Dental
8.2.5.1 Tissue Regeneration Materials
8.2.5.2 Dental Implants
8.2.5.3 Grafts and Substitutes
8.2.5.4 Others
8.2.6 Plastic Surgery
8.2.6.1 Soft Tissue Fillers
8.2.6.2 Peripheral Nerve Repair
8.2.6.3 Acellular Dermal Matrices
8.2.6.4 Others
8.2.7 Wound Healing
8.2.7.1 Fracture Healing Devices
8.2.7.2 Adhesion Barrier
8.2.7.3 Internal Tissue Sealant
8.2.7.4 Others
8.2.8 Tissue Engineering
8.2.9 Neurological/Central Nervous System
8.2.9.1 Neural Stem Cell Encapsulation
8.2.9.2 Shunting Systems
8.2.9.3 Hydrogel Scaffold for CNS Repair
8.2.9.4 Cortical Neural Prosthetics
8.2.9.5 Others
8.2.10 Others
8.3 North America Biomaterials Market (2018-2034) by Country
8.3.1 United States of America
8.3.1.1 United States of America Biomaterials Market (2018-2034) by Product Type
8.3.2 Canada
8.3.2.1 Canada Biomaterials Market (2018-2034) by Product Type
9 Europe Biomaterials Market (218-2034)
9.1 Europe Biomaterials Market (2018-2034) by Product Type
9.1.1 Market Overview
9.1.2 Metallic
9.1.2.1 Stainless Steel
9.1.2.2 Gold
9.1.2.3 Cobalt-Chrome
9.1.2.4 Others
9.1.3 Natural
9.1.3.1 Hyaluronic Acid
9.1.3.2 Cellulose
9.1.3.3 Gelatin
9.1.3.4 Others
9.1.4 Ceramics
9.1.4.1 Calcium Phosphate
9.1.4.2 Aluminum Oxide
9.1.4.3 Glass
9.1.4.4 Others
9.1.5 Polymers
9.1.5.1 Polyethylene
9.1.5.2 Polyester
9.1.5.3 Nylon
9.1.5.4 Others
9.2 Europe Biomaterials Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Orthopedic
9.2.2.1 Orthobiologics
9.2.2.2 Viscosupplementation
9.2.2.3 Spine Biomaterials
9.2.2.4 Others
9.2.3 Cardiovascular
9.2.3.1 Sensors
9.2.3.2 Stents
9.2.3.3 Pacemakers
9.2.3.4 Vascular Grafts
9.2.3.5 Others
9.2.4 Ophthalmology
9.2.4.1 Synthetic Corneas
9.2.4.2 Intraocular Lens
9.2.4.3 Contact Lens
9.2.4.4 Ocular Tissue Replacement
9.2.4.5 Others
9.2.5 Dental
9.2.5.1 Tissue Regeneration Materials
9.2.5.2 Dental Implants
9.2.5.3 Grafts and Substitutes
9.2.5.4 Others
9.2.6 Plastic Surgery
9.2.6.1 Soft Tissue Fillers
9.2.6.2 Peripheral Nerve Repair
9.2.6.3 Acellular Dermal Matrices
9.2.6.4 Others
9.2.7 Wound Healing
9.2.7.1 Fracture Healing Devices
9.2.7.2 Adhesion Barrier
9.2.7.3 Internal Tissue Sealant
9.2.7.4 Others
9.2.8 Tissue Engineering
9.2.9 Neurological/Central Nervous System
9.2.9.1 Neural Stem Cell Encapsulation
9.2.9.2 Shunting Systems
9.2.9.3 Hydrogel Scaffold for CNS Repair
9.2.9.4 Cortical Neural Prosthetics
9.2.9.5 Others
9.2.10 Others
9.3 Europe Biomaterials Market (2018-2034) by Country
9.3.1 United Kingdom
9.3.1.1 United Kingdom Biomaterials Market (2018-2034) by Product Type
9.3.2 Germany
9.3.2.1 Germany Biomaterials Market (2018-2034) by Product Type
9.3.3 France
9.3.3.1 France Biomaterials Market (2018-2034) by Product Type
9.3.4 Italy
9.3.4.1 Italy Biomaterials Market (2018-2034) by Product Type
9.3.5 Others
10 Asia Pacific Biomaterials Market (218-2034)
10.1 Asia Pacific Biomaterials Market (2018-2034) by Product Type
10.1.1 Market Overview
10.1.2 Metallic
10.1.2.1 Stainless Steel
10.1.2.2 Gold
10.1.2.3 Cobalt-Chrome
10.1.2.4 Others
10.1.3 Natural
10.1.3.1 Hyaluronic Acid
10.1.3.2 Cellulose
10.1.3.3 Gelatin
10.1.3.4 Others
10.1.4 Ceramics
10.1.4.1 Calcium Phosphate
10.1.4.2 Aluminum Oxide
10.1.4.3 Glass
10.1.4.4 Others
10.1.5 Polymers
10.1.5.1 Polyethylene
10.1.5.2 Polyester
10.1.5.3 Nylon
10.1.5.4 Others
10.2 Asia Pacific Biomaterials Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Orthopedic
10.2.2.1 Orthobiologics
10.2.2.2 Viscosupplementation
10.2.2.3 Spine Biomaterials
10.2.2.4 Others
10.2.3 Cardiovascular
10.2.3.1 Sensors
10.2.3.2 Stents
10.2.3.3 Pacemakers
10.2.3.4 Vascular Grafts
10.2.3.5 Others
10.2.4 Ophthalmology
10.2.4.1 Synthetic Corneas
10.2.4.2 Intraocular Lens
10.2.4.3 Contact Lens
10.2.4.4 Ocular Tissue Replacement
10.2.4.5 Others
10.2.5 Dental
10.2.5.1 Tissue Regeneration Materials
10.2.5.2 Dental Implants
10.2.5.3 Grafts and Substitutes
10.2.5.4 Others
10.2.6 Plastic Surgery
10.2.6.1 Soft Tissue Fillers
10.2.6.2 Peripheral Nerve Repair
10.2.6.3 Acellular Dermal Matrices
10.2.6.4 Others
10.2.7 Wound Healing
10.2.7.1 Fracture Healing Devices
10.2.7.2 Adhesion Barrier
10.2.7.3 Internal Tissue Sealant
10.2.7.4 Others
10.2.8 Tissue Engineering
10.2.9 Neurological/Central Nervous System
10.2.9.1 Neural Stem Cell Encapsulation
10.2.9.2 Shunting Systems
10.2.9.3 Hydrogel Scaffold for CNS Repair
10.2.9.4 Cortical Neural Prosthetics
10.2.9.5 Others
10.2.10 Others
10.3 Asia Pacific Biomaterials Market (2018-2034) by Country
10.3.1 China
10.3.1.1 China Biomaterials Market (2018-2034) by Product Type
10.3.2 Japan
10.3.2.1 Japan Biomaterials Market (2018-2034) by Product Type
10.3.3 India
10.3.3.1 India Biomaterials Market (2018-2034) by Product Type
10.3.4 ASEAN
10.3.4.1 ASEAN Biomaterials Market (2018-2034) by Product Type
10.3.5 Australia
10.3.5.1 Australia Biomaterials Market (2018-2034) by Product Type
10.3.6 Others
11 Latin America Biomaterials Market (218-2034)
11.1 Latin America Biomaterials Market (2018-2034) by Product Type
11.1.1 Market Overview
11.1.2 Metallic
11.1.2.1 Stainless Steel
11.1.2.2 Gold
11.1.2.3 Cobalt-Chrome
11.1.2.4 Others
11.1.3 Natural
11.1.3.1 Hyaluronic Acid
11.1.3.2 Cellulose
11.1.3.3 Gelatin
11.1.3.4 Others
11.1.4 Ceramics
11.1.4.1 Calcium Phosphate
11.1.4.2 Aluminum Oxide
11.1.4.3 Glass
11.1.4.4 Others
11.1.5 Polymers
11.1.5.1 Polyethylene
11.1.5.2 Polyester
11.1.5.3 Nylon
11.1.5.4 Others
11.2 Latin America Biomaterials Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Orthopedic
11.2.2.1 Orthobiologics
11.2.2.2 Viscosupplementation
11.2.2.3 Spine Biomaterials
11.2.2.4 Others
11.2.3 Cardiovascular
11.2.3.1 Sensors
11.2.3.2 Stents
11.2.3.3 Pacemakers
11.2.3.4 Vascular Grafts
11.2.3.5 Others
11.2.4 Ophthalmology
11.2.4.1 Synthetic Corneas
11.2.4.2 Intraocular Lens
11.2.4.3 Contact Lens
11.2.4.4 Ocular Tissue Replacement
11.2.4.5 Others
11.2.5 Dental
11.2.5.1 Tissue Regeneration Materials
11.2.5.2 Dental Implants
11.2.5.3 Grafts and Substitutes
11.2.5.4 Others
11.2.6 Plastic Surgery
11.2.6.1 Soft Tissue Fillers
11.2.6.2 Peripheral Nerve Repair
11.2.6.3 Acellular Dermal Matrices
11.2.6.4 Others
11.2.7 Wound Healing
11.2.7.1 Fracture Healing Devices
11.2.7.2 Adhesion Barrier
11.2.7.3 Internal Tissue Sealant
11.2.7.4 Others
11.2.8 Tissue Engineering
11.2.9 Neurological/Central Nervous System
11.2.9.1 Neural Stem Cell Encapsulation
11.2.9.2 Shunting Systems
11.2.9.3 Hydrogel Scaffold for CNS Repair
11.2.9.4 Cortical Neural Prosthetics
11.2.9.5 Others
11.2.10 Others
11.3 Latin America Biomaterials Market (2018-2034) by Country
11.3.1 Brazil
11.3.1.1 Brazil Biomaterials Market (2018-2034) by Product Type
11.3.2 Argentina
11.3.2.1 Argentina Biomaterials Market (2018-2034) by Product Type
11.3.3 Mexico
11.3.3.1 Mexico Biomaterials Market (2018-2034) by Product Type
11.3.4 Others
12 Middle East and Africa Biomaterials Market (218-2034)
12.1 Middle East and Africa Biomaterials Market (2018-2034) by Product Type
12.1.1 Market Overview
12.1.2 Metallic
12.1.2.1 Stainless Steel
12.1.2.2 Gold
12.1.2.3 Cobalt-Chrome
12.1.2.4 Others
12.1.3 Natural
12.1.3.1 Hyaluronic Acid
12.1.3.2 Cellulose
12.1.3.3 Gelatin
12.1.3.4 Others
12.1.4 Ceramics
12.1.4.1 Calcium Phosphate
12.1.4.2 Aluminum Oxide
12.1.4.3 Glass
12.1.4.4 Others
12.1.5 Polymers
12.1.5.1 Polyethylene
12.1.5.2 Polyester
12.1.5.3 Nylon
12.1.5.4 Others
12.2 Middle East and Africa Biomaterials Market (2018-2034) by Application
12.2.1 Market Overview
12.2.2 Orthopedic
12.2.2.1 Orthobiologics
12.2.2.2 Viscosupplementation
12.2.2.3 Spine Biomaterials
12.2.2.4 Others
12.2.3 Cardiovascular
12.2.3.1 Sensors
12.2.3.2 Stents
12.2.3.3 Pacemakers
12.2.3.4 Vascular Grafts
12.2.3.5 Others
12.2.4 Ophthalmology
12.2.4.1 Synthetic Corneas
12.2.4.2 Intraocular Lens
12.2.4.3 Contact Lens
12.2.4.4 Ocular Tissue Replacement
12.2.4.5 Others
12.2.5 Dental
12.2.5.1 Tissue Regeneration Materials
12.2.5.2 Dental Implants
12.2.5.3 Grafts and Substitutes
12.2.5.4 Others
12.2.6 Plastic Surgery
12.2.6.1 Soft Tissue Fillers
12.2.6.2 Peripheral Nerve Repair
12.2.6.3 Acellular Dermal Matrices
12.2.6.4 Others
12.2.7 Wound Healing
12.2.7.1 Fracture Healing Devices
12.2.7.2 Adhesion Barrier
12.2.7.3 Internal Tissue Sealant
12.2.7.4 Others
12.2.8 Tissue Engineering
12.2.9 Neurological/Central Nervous System
12.2.9.1 Neural Stem Cell Encapsulation
12.2.9.2 Shunting Systems
12.2.9.3 Hydrogel Scaffold for CNS Repair
12.2.9.4 Cortical Neural Prosthetics
12.2.9.5 Others
12.2.10 Others
12.3 Middle East and Africa Biomaterials Market (2018-2034) by Country
12.3.1 Saudi Arabia
12.3.1.1 Saudi Arabia Biomaterials Market (2018-2034) by Product Type
12.3.2 United Arab Emirates
12.3.2.1 United Arab Emirates Biomaterials Market (2018-2034) by Product Type
12.3.3 Nigeria
12.3.3.1 Nigeria Biomaterials Market (2018-2034) by Product Type
12.3.4 South Africa
12.3.4.1 South Africa Biomaterials Market (2018-2034) by Product Type
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Initiatives
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Zimmer Biomet
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 Noble Biomaterials Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 BASF SE
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Covestro AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Celanese Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Carpenter Technology Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Evonik Industries AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Koninklijke DSM N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Corbion NV
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Victrex plc
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
17.12 CeramTec GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Company News and Development
17.12.5 Certifications
17.13 Coorstek Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Company News and Development
17.13.5 Certifications
18 Global Biomaterials Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Koninklijke DSM N.V.
  • Corbion N.V.
  • Zimmer Biomet
  • Noble Biomaterials Inc.

Table Information